Astrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–29 of 29 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02942264	Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma	terminated	Phase 1 / Phase 2	53	National Cancer Institute (NCI)NIH	1	Feb 23, 2026	clinicaltrials
NCT07121829	Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors	terminated	Phase 1	44	Day One Biopharmaceuticals, Inc.INDUSTRY